首页 | 本学科首页   官方微博 | 高级检索  
检索        

脂蟾毒配基、华蟾酥毒基、蟾毒灵配伍对BEL-7402人肝癌细胞的抑制作用
引用本文:韩欣汝,吴世福,张,超,盛华刚,林桂涛.脂蟾毒配基、华蟾酥毒基、蟾毒灵配伍对BEL-7402人肝癌细胞的抑制作用[J].山东中医药大学学报,2014(3):266-269.
作者姓名:韩欣汝  吴世福      盛华刚  林桂涛
作者单位:[1]山东中医药大学,山东济南250355 [2]山东省医疗器械质量检验中心,山东济南250101
基金项目:十一五重大新药创制项目(编号:2009ZX09301-013)
摘    要:目的:研究蟾酥中脂蟾毒配基、华蟾酥毒基和蟾毒灵三种成分单体及配伍对BEL-7402人肝癌细胞的抑制作用。方法:采用MTT法测定蟾毒灵、华蟾酥毒基、脂蟾毒配基单体不同浓度和时间点,三种成分两两配伍以及三种成分配伍对BEL-7402人肝癌细胞增殖的抑制作用。结果:蟾毒灵对BEL-7402人肝癌细胞增殖的抑制作用最强,其次是华蟾酥毒基,脂蟾毒配基的作用最弱;脂蟾毒配基不能增强华蟾酥毒基、蟾毒灵的作用,且有抑制作用的趋势;华蟾酥毒基与蟾毒灵混合使用与单独使用的抑制作用无明显区别。结论:欲发挥三种成分的抗肿瘤作用,应该单独使用,或者华蟾酥毒基与蟾毒灵混合使用。

关 键 词:华蟾酥毒基  脂蟾毒配基  蟾毒灵  MTF法

Study on the Anti-tumor Effect of RBG,CBG and BL on BEL-7402 Human Hepatoma Cells
HAN Xinrul,WU Shifu,ZHANG Chaol,SHENG Huagangl,LIN Guitao.Study on the Anti-tumor Effect of RBG,CBG and BL on BEL-7402 Human Hepatoma Cells[J].Journal of Shandong University of Traditional Chinese Medicine,2014(3):266-269.
Authors:HAN Xinrul  WU Shifu  ZHANG Chaol  SHENG Huagangl  LIN Guitao
Institution:1.Shandong University of Traditional Chinese Medicine,Jinan 250355,China;2.Medical Equipment Quality Inspection Center of Shandong Province,Jinan 250101,China)
Abstract:Objective:Make a study of the anti-tumor effect of the active ingredients in resibufogenin(RBC), cinobubufagin(CBG),bufalin(BL) belonging to Venenum Bufonis on BEL-7402 liver cancer cells when they are used respectively or in combination. Methods:The MTT is used to find out the different concentrations and time points of RBG,CBG and BL,and the anti-tumor effects of their compatibility between two and three components on BEL-7402 human hepatoma cells. In different experiments,two of the three toad poison drugs or all of the three ones called the orthogonal sults:BL is the most effective one,followed by CBG test are mixed at different concentration and time. Re- ,and RBG is the worst one. With RBG mixed,BL and CBG can not be strengthened and they are inhibited. There is no obvious difference when CBG and BL are used separately or in combination. Conclusion lThe three components can show their anti-tumor function ef- fectively when they are used separately or CBG and BL are used in combination.
Keywords:einobubufagin  resibufogenin  bufalin  MTT method
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号